Serotonin–dopamine reuptake inhibitor
A serotonin–dopamine reuptake inhibitor (SDRI) is a type of drug which acts as a reuptake inhibitor of the monoamine neurotransmitters serotonin and dopamine by blocking the actions of the serotonin transporter (SERT) and dopamine transporter (DAT), respectively. This in turn leads to increased extracellular concentrations of serotonin and dopamine, and, therefore, an increase in serotonergic and dopaminergic neurotransmission. A closely related type of drug is a serotonin–dopamine releasing agent (SDRA).
class
AN-788DSRIDSRI (disambiguation)Dopamine-serotonin reuptake inhibitorDopamine and serotonin reuptake inhibitorList of antidepressantsList of investigational antidepressantsMonoamine reuptake inhibitorRTI-83Reuptake inhibitorSDRISerotonin-dopamine reuptake inhibitorSerotonin and dopamine reuptake inhibitorSerotonin antagonist and reuptake inhibitorSerotonin–dopamine releasing agentUWA-101
Link from a Wikipage to another Wikipage
class
primaryTopic
Serotonin–dopamine reuptake inhibitor
A serotonin–dopamine reuptake inhibitor (SDRI) is a type of drug which acts as a reuptake inhibitor of the monoamine neurotransmitters serotonin and dopamine by blocking the actions of the serotonin transporter (SERT) and dopamine transporter (DAT), respectively. This in turn leads to increased extracellular concentrations of serotonin and dopamine, and, therefore, an increase in serotonergic and dopaminergic neurotransmission. A closely related type of drug is a serotonin–dopamine releasing agent (SDRA).
has abstract
A serotonin–dopamine reuptake ...... pamine releasing agent (SDRA).
@en
Wikipage page ID
35,616,296
page length (characters) of wiki page
Wikipage revision ID
993,666,149
Link from a Wikipage to another Wikipage
wikiPageUsesTemplate
comment
A serotonin–dopamine reuptake ...... pamine releasing agent (SDRA).
@en
label
Serotonin–dopamine reuptake inhibitor
@en